<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151269">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01801189</url>
  </required_header>
  <id_info>
    <org_study_id>H001</org_study_id>
    <nct_id>NCT01801189</nct_id>
  </id_info>
  <brief_title>Preoperative Pain Control in Gastric Bypass Surgery Patients</brief_title>
  <official_title>A Randomized Placebo-Controlled Study of Whether Pre-operative Pregabalin 300 mg Will Improve Pain Control in Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass (Bariatric Surgery)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Legacy Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Legacy Health System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized clinical trial to evaluate whether a single pre-operative dose of Pregabalin will
      alleviate post-operative pain and decrease post-operative analgesic requirements in morbidly
      obese patients undergoing laparoscopic gastric bypass surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pregabalin is a popular adjunct for relieving neuropathic pain in diabetics. There have been
      multiple studies evaluating its use in pre and post-operative pain control in various
      surgeries. Post-operative pain control is a challenging problem in bariatric patients due to
      the high doses of narcotic required, related to the high body mass, and the danger of
      concomitant respiratory depression. In the obese patient, the goal of postoperative pain
      management is provision of comfort, early mobilization and improved respiratory function,
      without causing inadequate pain control, respiratory compromise or increased nausea.

      Methods: A Randomized Controlled Trial, whereby patients undergoing Laparoscopic Roux-en-Y
      gastric bypass will be administered a single pre-operative dose of Pregabalin or a placebo.
      We plan to follow their immediate post-operative course in the hospital, with regard to the
      following primary endpoints:

        -  Post-operative analgesic requirements

        -  Post-operative pain scale (rated 0-10)

        -  Episodes of vomiting

        -  Post-operative antiemetic requirement

        -  Length of stay
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Post-operative pain medication requirements</measure>
    <time_frame>Evaluated every 4 hours and 1 hour after pain medications are given post-operatively during hospitalization, for up to 5 days.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative Pain Scale</measure>
    <time_frame>Evaluated every 4 hours and 1 hour after pain medications are given post-operatively during hospitalization, for up to 5 days.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Episodes of vomiting</measure>
    <time_frame>Evaluated every 4 hours and 1 hour after pain medications are given post-operatively during hospitalization, for up to 5 days.</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Post-operative Pain</condition>
  <arm_group>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single, 300 mg pre-operative oral dose of Pregabalin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar Pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single, placebo pre-operative dose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>One 300 mg oral dose of Pregabalin given before surgery.</description>
    <arm_group_label>Pregabalin</arm_group_label>
    <other_name>Lyrica</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (for Pregabalin)</intervention_name>
    <description>One oral dose of placebo given before surgery.</description>
    <arm_group_label>Sugar Pill</arm_group_label>
    <other_name>Sugar pill manufactured to mimic Pregabalin 300 mg tablet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing laparoscopic Roux-en-Y gastric bypass surgery.

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valerie Halpin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Legacy Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Reiter, RN</last_name>
    <email>areiter@lhs.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Legacy Good Samaritan Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Reiter, RN</last_name>
      <email>areiter@lhs.org</email>
    </contact>
    <investigator>
      <last_name>Valerie Halpin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 2, 2014</lastchanged_date>
  <firstreceived_date>February 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Legacy Health System</investigator_affiliation>
    <investigator_full_name>Valerie Halpin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
